Logo Logo
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Springe zu: 2025 | 2024 | 2023 | 2022 | 2018
Anzahl der Publikationen: 7

2025

Afzali, Ali Maisam ORCID logoORCID: https://orcid.org/0000-0002-3256-5298; Vosko, Milan; Reinhardt, Nya; Zinevych, Iaroslav; Gmeiner, Vincent; Korn, Thomas ORCID logoORCID: https://orcid.org/0000-0002-3633-0955; Gasperi, Christiane; Berthele, Achim; Feneberg, Emily und Hemmer, Bernhard ORCID logoORCID: https://orcid.org/0000-0001-5985-6784 (2025): Serum neurofilament light chain predicts disease severity in axonal variants of acute immune neuropathie. A retrospective monocentric cohort study. In: European Journal of Neurology, Bd. 32, Nr. 1, e16539 [PDF, 607kB]

2024

Wolff, Andreas; Demleitner, Antonia Franziska; Feneberg, Emily und Lingor, Paul (2024): Den Rauch riechen, bevor man das Feuer sieht – die oligosymptomatische Prodromalphase neurodegenerativer Erkrankungen. In: Nervenarzt [Forthcoming] [PDF, 382kB]

Koch, Jan C; Leha, Andreas; Bidner, Helen; Cordts, Isabell; Dorst, Johannes; Günther, René; Zeller, Daniel; Braun, Nathalie; Metelmann, Moritz; Corcia, Philippe; Cruz, Elisa De La; Weydt, Patrick; Meyer, Thomas; Großkreutz, Julian; Soriani, Marie-Hélène; Attarian, Shahram; Weishaupt, Jochen H; Weyen, Ute; Kuttler, Josua; Zurek, Gabriela; Rogers, Mary-Louise; Feneberg, Emily; Deschauer, Marcus ORCID logoORCID: https://orcid.org/0000-0001-6116-6790; Neuwirth, Christoph; Wuu, Joanne; Ludolph, Albert C; Schmidt, Jens; Remane, Yvonne; Camu, William; Friede, Tim; Benatar, Michael; Weber, Markus und Lingor, Paul (2024): Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS). A phase 2, randomised, double-blind, placebo-controlled trial. In: Lancet Neurology, Bd. 23, Nr. 11: S. 1133-1146 [PDF, 849kB]

2023

Cordts, Isabell; Wachinger, Annika; Scialo, Carlo; Lingor, Paul; Polymenidou, Magdalini; Buratti, Emanuele und Feneberg, Emily (2023): TDP-43 Proteinopathy Specific Biomarker Development. In: Cells, Bd. 12, Nr. 4, 597 [PDF, 1MB]

Wolff, Andreas; Schumacher, Nicolas U.; Puerner, Dominik; Machetanz, Gerrit; Demleitner, Antonia F.; Feneberg, Emily; Hagemeier, Maike und Lingor, Paul (2023): Parkinson's disease therapy: what lies ahead? In: Journal of Neural Transmission, Bd. 130, Nr. 6: S. 793-820 [PDF, 1MB]

2022

Lingor, Paul; Demleitner, Antonia F.; Wolff, Andreas W. und Feneberg, Emily (2022): SARS-CoV-2 and neurodegenerative diseases: what we know and what we don't. In: Journal of Neural Transmission, Bd. 129, Nr. 9: S. 1155-1167 [PDF, 870kB]

2018

Steinacker, Petra; Verde, Federico; Fang, Lubin; Feneberg, Emily; Oeckl, Patrick; Roeber, Sigrun; Anderl-Straub, Sarah; Danek, Adrian; Diehl-Schmid, Janine; Fassbender, Klaus; Fliessbach, Klaus; Foerstl, Hans; Giese, Armin; Jahn, Holger; Kassubek, Jan; Kornhuber, Johannes; Landwehrmeyer, G. Bernhard; Lauer, Martin; Pinkhardt, Elmar Hans; Prudlo, Johannes; Rosenbohm, Angela; Schneider, Anja; Schröter, Matthias L.; Tumani, Hayrettin; Arnim, Christine A. F. von; Weishaupt, Jochen; Weydt, Patrick; Ludolph, Albert C.; Yilmazer Hanke, Deniz und Otto, Markus (2018): Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression. In: Journal of Neurology Neurosurgery and Psychiatry, Bd. 89, Nr. 3: S. 239-247 [PDF, 2MB]

Diese Liste wurde am Sat Jan 4 21:15:17 2025 CET erstellt.